Cai Yu , Minae Ide , Taiki Sugimoto , Rei Otsuka , Koji Takahashi , Masaki Takiwaki , Kiyoshi Tanaka , Hiroaki Kanouchi , Shigeo Takenaka , Takashi Sakurai , Shumpei Niida , Akiko Kuwabara
{"title":"社区老年人血清维生素D代谢物水平与认知功能之间的关系:一项横断面研究。","authors":"Cai Yu , Minae Ide , Taiki Sugimoto , Rei Otsuka , Koji Takahashi , Masaki Takiwaki , Kiyoshi Tanaka , Hiroaki Kanouchi , Shigeo Takenaka , Takashi Sakurai , Shumpei Niida , Akiko Kuwabara","doi":"10.1016/j.clnesp.2025.08.032","DOIUrl":null,"url":null,"abstract":"<div><h3>Background & aims</h3><div>Vitamin D deficiency has been associated with cognitive decline and Alzheimer's disease (AD); however, findings remain inconsistent. Assessing vitamin D status based solely on total 25-hydroxyvitamin D [25(OH)D] may be insufficient, and other metabolites, such as 24,25-dihydroxyvitamin D<sub>3</sub> [24,25(OH)<sub>2</sub>D<sub>3</sub>] and 3-epimer-25-hydroxyvitamin D<sub>3</sub> [3-epi-25(OH)D<sub>3</sub>], may provide additional insights. This study aimed to examine the association between serum vitamin D metabolite concentrations and cognitive function in older adults.</div></div><div><h3>Methods</h3><div>A cross-sectional study was conducted involving 289 community-dwelling participants aged 65–85 years clinically diagnosed with AD, mild cognitive impairment (MCI), or were cognitively normal (CN). Cognitive function was assessed using the Mini-Mental State Examination (MMSE). Serum concentrations of 25-hydroxyvitamin D<sub>3</sub> [25(OH)D<sub>3</sub>], 25-hydroxyvitamin D<sub>2</sub> [25(OH)D<sub>2</sub>], 24,25(OH)<sub>2</sub>D<sub>3</sub>, 3-epi-25(OH)D<sub>3</sub>, and 1,25-dihydroxyvitamin D<sub>3</sub> [1,25(OH)<sub>2</sub>D<sub>3</sub>] were measured using liquid chromatography-tandem mass spectrometry (LC-MS/MS). The Vitamin D metabolite ratio (VMR) was calculated as 24,25(OH)<sub>2</sub>D<sub>3</sub>/25(OH)D<sub>3</sub> × 100 (%). Associations among metabolite concentrations, MMSE scores, and AD prevalence were analyzed.</div></div><div><h3>Results</h3><div>Participants had relatively high serum total 25(OH)D levels (median: 23.5 ng/mL), with males showing higher vitamin D metabolite concentrations. Total 25(OH)D correlated with 24,25(OH)<sub>2</sub>D<sub>3</sub>, 3-epi-25(OH)D<sub>3</sub>, and VMR. In males, 3-epi-25(OH)D<sub>3</sub> and 24,25(OH)<sub>2</sub>D<sub>3</sub> were associated with lower MMSE scores (p < 0.01) and higher AD risk (OR = 2.78, p = 0.03). In females, VMR was associated with higher MMSE scores (p = 0.01) and lower AD risk (OR = 0.64, p < 0.01), while 1,25(OH)<sub>2</sub>D<sub>3</sub> was linked to higher AD risk (OR = 1.04, p = 0.01) and quartile 2 with lower MCI risk (p < 0.05).</div></div><div><h3>Conclusions</h3><div>Sex-based differences in vitamin D–cognition associations may reflect disparities in vitamin D levels and hormonal effects, such as estrogen-enhancing and testosterone-suppressing metabolism. 1,25(OH)<sub>2</sub>D<sub>3</sub>, VMR, and 3-epi-25(OH)D<sub>3</sub> may be more sensitive than total 25(OH)D.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"69 ","pages":"Pages 785-793"},"PeriodicalIF":2.6000,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Association between serum vitamin D metabolite levels and cognitive function in community-dwelling older adults: A cross-sectional study\",\"authors\":\"Cai Yu , Minae Ide , Taiki Sugimoto , Rei Otsuka , Koji Takahashi , Masaki Takiwaki , Kiyoshi Tanaka , Hiroaki Kanouchi , Shigeo Takenaka , Takashi Sakurai , Shumpei Niida , Akiko Kuwabara\",\"doi\":\"10.1016/j.clnesp.2025.08.032\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background & aims</h3><div>Vitamin D deficiency has been associated with cognitive decline and Alzheimer's disease (AD); however, findings remain inconsistent. Assessing vitamin D status based solely on total 25-hydroxyvitamin D [25(OH)D] may be insufficient, and other metabolites, such as 24,25-dihydroxyvitamin D<sub>3</sub> [24,25(OH)<sub>2</sub>D<sub>3</sub>] and 3-epimer-25-hydroxyvitamin D<sub>3</sub> [3-epi-25(OH)D<sub>3</sub>], may provide additional insights. This study aimed to examine the association between serum vitamin D metabolite concentrations and cognitive function in older adults.</div></div><div><h3>Methods</h3><div>A cross-sectional study was conducted involving 289 community-dwelling participants aged 65–85 years clinically diagnosed with AD, mild cognitive impairment (MCI), or were cognitively normal (CN). Cognitive function was assessed using the Mini-Mental State Examination (MMSE). Serum concentrations of 25-hydroxyvitamin D<sub>3</sub> [25(OH)D<sub>3</sub>], 25-hydroxyvitamin D<sub>2</sub> [25(OH)D<sub>2</sub>], 24,25(OH)<sub>2</sub>D<sub>3</sub>, 3-epi-25(OH)D<sub>3</sub>, and 1,25-dihydroxyvitamin D<sub>3</sub> [1,25(OH)<sub>2</sub>D<sub>3</sub>] were measured using liquid chromatography-tandem mass spectrometry (LC-MS/MS). The Vitamin D metabolite ratio (VMR) was calculated as 24,25(OH)<sub>2</sub>D<sub>3</sub>/25(OH)D<sub>3</sub> × 100 (%). Associations among metabolite concentrations, MMSE scores, and AD prevalence were analyzed.</div></div><div><h3>Results</h3><div>Participants had relatively high serum total 25(OH)D levels (median: 23.5 ng/mL), with males showing higher vitamin D metabolite concentrations. Total 25(OH)D correlated with 24,25(OH)<sub>2</sub>D<sub>3</sub>, 3-epi-25(OH)D<sub>3</sub>, and VMR. In males, 3-epi-25(OH)D<sub>3</sub> and 24,25(OH)<sub>2</sub>D<sub>3</sub> were associated with lower MMSE scores (p < 0.01) and higher AD risk (OR = 2.78, p = 0.03). In females, VMR was associated with higher MMSE scores (p = 0.01) and lower AD risk (OR = 0.64, p < 0.01), while 1,25(OH)<sub>2</sub>D<sub>3</sub> was linked to higher AD risk (OR = 1.04, p = 0.01) and quartile 2 with lower MCI risk (p < 0.05).</div></div><div><h3>Conclusions</h3><div>Sex-based differences in vitamin D–cognition associations may reflect disparities in vitamin D levels and hormonal effects, such as estrogen-enhancing and testosterone-suppressing metabolism. 1,25(OH)<sub>2</sub>D<sub>3</sub>, VMR, and 3-epi-25(OH)D<sub>3</sub> may be more sensitive than total 25(OH)D.</div></div>\",\"PeriodicalId\":10352,\"journal\":{\"name\":\"Clinical nutrition ESPEN\",\"volume\":\"69 \",\"pages\":\"Pages 785-793\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-09-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical nutrition ESPEN\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2405457725029183\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"NUTRITION & DIETETICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical nutrition ESPEN","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405457725029183","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
Association between serum vitamin D metabolite levels and cognitive function in community-dwelling older adults: A cross-sectional study
Background & aims
Vitamin D deficiency has been associated with cognitive decline and Alzheimer's disease (AD); however, findings remain inconsistent. Assessing vitamin D status based solely on total 25-hydroxyvitamin D [25(OH)D] may be insufficient, and other metabolites, such as 24,25-dihydroxyvitamin D3 [24,25(OH)2D3] and 3-epimer-25-hydroxyvitamin D3 [3-epi-25(OH)D3], may provide additional insights. This study aimed to examine the association between serum vitamin D metabolite concentrations and cognitive function in older adults.
Methods
A cross-sectional study was conducted involving 289 community-dwelling participants aged 65–85 years clinically diagnosed with AD, mild cognitive impairment (MCI), or were cognitively normal (CN). Cognitive function was assessed using the Mini-Mental State Examination (MMSE). Serum concentrations of 25-hydroxyvitamin D3 [25(OH)D3], 25-hydroxyvitamin D2 [25(OH)D2], 24,25(OH)2D3, 3-epi-25(OH)D3, and 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] were measured using liquid chromatography-tandem mass spectrometry (LC-MS/MS). The Vitamin D metabolite ratio (VMR) was calculated as 24,25(OH)2D3/25(OH)D3 × 100 (%). Associations among metabolite concentrations, MMSE scores, and AD prevalence were analyzed.
Results
Participants had relatively high serum total 25(OH)D levels (median: 23.5 ng/mL), with males showing higher vitamin D metabolite concentrations. Total 25(OH)D correlated with 24,25(OH)2D3, 3-epi-25(OH)D3, and VMR. In males, 3-epi-25(OH)D3 and 24,25(OH)2D3 were associated with lower MMSE scores (p < 0.01) and higher AD risk (OR = 2.78, p = 0.03). In females, VMR was associated with higher MMSE scores (p = 0.01) and lower AD risk (OR = 0.64, p < 0.01), while 1,25(OH)2D3 was linked to higher AD risk (OR = 1.04, p = 0.01) and quartile 2 with lower MCI risk (p < 0.05).
Conclusions
Sex-based differences in vitamin D–cognition associations may reflect disparities in vitamin D levels and hormonal effects, such as estrogen-enhancing and testosterone-suppressing metabolism. 1,25(OH)2D3, VMR, and 3-epi-25(OH)D3 may be more sensitive than total 25(OH)D.
期刊介绍:
Clinical Nutrition ESPEN is an electronic-only journal and is an official publication of the European Society for Clinical Nutrition and Metabolism (ESPEN). Nutrition and nutritional care have gained wide clinical and scientific interest during the past decades. The increasing knowledge of metabolic disturbances and nutritional assessment in chronic and acute diseases has stimulated rapid advances in design, development and clinical application of nutritional support. The aims of ESPEN are to encourage the rapid diffusion of knowledge and its application in the field of clinical nutrition and metabolism. Published bimonthly, Clinical Nutrition ESPEN focuses on publishing articles on the relationship between nutrition and disease in the setting of basic science and clinical practice. Clinical Nutrition ESPEN is available to all members of ESPEN and to all subscribers of Clinical Nutrition.